Antiproliferative Activity of Withanolides against Human Breast Cancer Cell LinesMACHIN, Rubén P; VELEIRO, Adriana S; NICOTRA, Viviana E et al.Journal of natural products (Print). 2010, Vol 73, Num 5, pp 966-968, issn 0163-3864, 3 p.Article

Targeting the HOX/PBX dimer in breast cancerMORGAN, Richard; BOXALL, Angie; HARRINGTON, Kevin J et al.Breast cancer research and treatment. 2012, Vol 136, Num 2, pp 389-398, issn 0167-6806, 10 p.Article

Characterization of a growth factor that binds exclusively to the erbB-2 receptor and induces cellular responsesLUPU, R; COLOMER, R; KANNAN, B et al.Proceedings of the National Academy of Sciences of the United States of America. 1992, Vol 89, Num 6, pp 2287-2291, issn 0027-8424Article

A combination of two immunotoxins exerts synergistic cytotoxic activity against human breast-cancer cell linesCREWS, J. R; MAIER, L. A; BAST, R. C et al.International journal of cancer. 1992, Vol 51, Num 5, pp 772-779, issn 0020-7136Article

Direct-double-differential PCR for gene dosage quantification of c-mycBECKMANN, A; VOGT, U; HUDA, N et al.Clinical chemistry (Baltimore, Md.). 1999, Vol 45, Num 1, pp 141-143, issn 0009-9147Article

Expression of the c-erbB2 gene in the BT474 human mammary tumor cell line : measurement of c-erbB2 mRNA half-lifePASLEAU, F; GROOTECLAES, M; GOL-WINKLER, R et al.Oncogene (Basingstoke). 1993, Vol 8, Num 4, pp 849-854, issn 0950-9232Article

Migrating and circulating breast carcinoma cells are within active phases of the cell cycleKUBENS, Britta S; FELDNER, Julia C; BRANDT, Burkhard et al.Anticancer research. 2002, Vol 22, Num 2A, pp 899-903, issn 0250-7005Article

Disulfide-linked and noncovalent dimers of p185^HER-2 in human breast carcinoma cellsLIN, Y. J; CHRISTIANSON, T. A; CLINTON, G. M et al.Journal of cellular biochemistry. 1992, Vol 49, Num 3, pp 290-295, issn 0730-2312Article

Synthesis of new oxathiazinane dioxides and their in vitro cancer cell growth inhibitory activityBORCARD, Françoise; BAUD, Matthias; BELLO, Claudia et al.Bioorganic & medicinal chemistry letters (Print). 2010, Vol 20, Num 17, pp 5353-5356, issn 0960-894X, 4 p.Article

Laminin activates the p185^HER2 oncoprotein and mediates growth inhibition of breast carcinoma cellsTAGLIABUE, E; ARDINI, E; PELLEGRINI, R et al.British journal of cancer. 1996, Vol 74, Num 9, pp 1427-1433, issn 0007-0920Article

Murine monoclonal anti-idiotypic antibody as a surrogate antigen for human Her-2/neuBARAL, Rathindranath; SHERRAT, Amanda; DAS, Ruma et al.International journal of cancer. 2001, Vol 92, Num 1, pp 88-95, issn 0020-7136Article

Antitumor agents. 254. Synthesis and biological evaluation of novel neo-tanshinlactone analogues as potent anti-breast cancer agentsXIHONG WANG; NAKAGAWA-GOTO, Kyoko; BASTOW, Kenneth F et al.Journal of medicinal chemistry (Print). 2006, Vol 49, Num 18, pp 5631-5634, issn 0022-2623, 4 p.Article

Gonadotropin-releasing hormone (GnRH)-binding sites in human breast cancer cell lines and inhibitory effects of GnRH antagonistsEIDNE, K. A; FLANAGAN, C. A; HARRIS, N. S et al.The Journal of clinical endocrinology and metabolism. 1987, Vol 64, Num 3, pp 425-432, issn 0021-972XArticle

Regulation of the human retinoic acid receptor α gene in the estrogen receptor negative human breast carcinoma cell lines SKBR-3 and MDA-MB-435RISHI, A. K; GERALD, T. M; SHAO, Z.-M et al.Cancer research (Baltimore). 1996, Vol 56, Num 22, pp 5246-5252, issn 0008-5472Article

Reduction of erbB2 gene product in mamma carcinoma cell lines by erB2 mRNA-specific and tyrosine kinase consensus phosphorothioate antisense oligonucleotidesBERTRAM, J; KILLIAN, M; BRYSCH, W et al.Biochemical and biophysical research communications (Print). 1994, Vol 200, Num 1, pp 661-667, issn 0006-291XArticle

Heregulin induces increase in sensitivity of an erbB-2-overexpressing breast cancer cell type to lysis by lymphokine-activated killer cellsCARDILLO, M; YANKELEVICH, B; MAZUMDER, A et al.Cancer immunology and immunotherapy. 1996, Vol 43, Num 1, pp 19-25, issn 0340-7004Article

Ligand-like effects induced by anti-c-erbB-2 antibodies do not correlate with an are not required for growth inhibition of human carcinoma cellsSHAWVER, L. K; MANN, E; ELLIGER, S. S et al.Cancer research (Baltimore). 1994, Vol 54, Num 5, pp 1367-1373, issn 0008-5472Article

Synthesis and antiproliferative evaluation of 5-oxo and 5-thio derivatives of 1,4-diaryl tetrazolesGUNDUGOLA, Aditya S; CHANDRA, Kusum Lata; PERCHELLET, Elisabeth M et al.Bioorganic & medicinal chemistry letters (Print). 2010, Vol 20, Num 13, pp 3920-3924, issn 0960-894X, 5 p.Article

Affibody-displaying bionanocapsules for specific drug delivery to HER2-expressing cancer cellsSHISHIDO, Takuya; MIEDA, Hiroaki; SANG YOUN HWANG et al.Bioorganic & medicinal chemistry letters (Print). 2010, Vol 20, Num 19, pp 5726-5731, issn 0960-894X, 6 p.Article

Synthesis and evaluation of Hsp90 inhibitors that contain the 1,4-naphthoquinone scaffoldKYLE HADDEN, M; HILL, Stephanie A; DAVENPORT, Jason et al.Bioorganic & medicinal chemistry. 2009, Vol 17, Num 2, pp 634-640, issn 0968-0896, 7 p.Article

Synthesis and SAR study of N-(4-hydroxy-3-(2-hydroxynaphthalene-1-yl)phenyl)-arylsulfonamides : Heat shock protein 90 (Hsp90) inhibitors with submicromolar activity in an in vitro assayGANESH, Thota; THEPCHATRI, Pahk; LIAN LI et al.Bioorganic & medicinal chemistry letters (Print). 2008, Vol 18, Num 18, pp 4982-4987, issn 0960-894X, 6 p.Article

Pharmacological blockade of fatty acid synthase (FASH) reverses acquired autoresistance to trastuzumab (herceptin™) by transcriptionally inhibiting 'HER2 super-expression' occurring in high-dose trastuzumab-conditioned SKBR3/Tzb100 breast cancer cellsVAZQUEZ-MARTIN, Alejandro; COLOMER, Ramon; BRUNET, Joan et al.International journal of oncology. 2007, Vol 31, Num 4, pp 769-776, issn 1019-6439, 8 p.Article

Cytotoxic diterpenoids from the hybrid soft coral Sinularia maxima × Sinularia polydactylaNASR KAMEL, Haidy; FERREIRA, Daneel; GARCIA-FEMANDEZ, Luis F et al.Journal of natural products (Print). 2007, Vol 70, Num 8, pp 1223-1227, issn 0163-3864, 5 p.Article

Synthesis and antitumor evaluation of novel 5-substituted-4-hydroxy-8-nitroquinazolines as EGFR signaling-targeted inhibitorsYI JIN; LI, Hui-Yuan; LIN, Li-Ping et al.Bioorganic & medicinal chemistry. 2005, Vol 13, Num 19, pp 5613-5622, issn 0968-0896, 10 p.Article

Interleukin-21 Increases Direct Cytotoxicity and IFN-γ Production of Ex Vivo Expanded NK Cells towards Breast Cancer CellsPARK, Young-Ki; SHIN, Dong-Jun; YOUNG JONG JEGAL et al.Anticancer research. 2012, Vol 32, Num 3, pp 839-846, issn 0250-7005, 8 p.Article